Trial NCT01996696

View at ClinicalTrials.gov 
Org. Study IDs: CCI-Usmani-01

Last trial update was posted on 2024-01-30

MeSH Interventions

Metformin

MeSH Conditions

Adenocarcinoma Metabolic Syndrome Prostatic Neoplasms Weight Gain

Other Conditions

Prostatic Neoplasm

Stopping Reasons

Results of interim analysis indicate no statistically significant difference in the primary objective between the two arms at baseline and 12 months of follow-up.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID